Author

N.-K. Lee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Liu· 3 shared S. Bidlingmaier· 3 shared Y. Su· 3 shared C. R. Behrens· 1 shared S. Lang· 1 shared X. Zhang· 1 shared Y. Seo· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

B. Liu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A non-ligand surrogate agonist antibody that enhances canonical Wnt signaling and bone regeneration

N.-K. Lee, S. Bidlingmaier, Y. Su, Y. Seo, B. Liu

This paper describes an antibody that enhances Wnt signaling and promotes bone regeneration without requiring exogenous Wnt ligands, showing efficacy in a mouse model of bone loss.

bioRxiv · Sep 25, 2022 · PreprintBioengineering

ALPPL2 is a highly specific and targetable tumor cell surface antigen

Y. Su, X. Zhang, S. Bidlingmaier, C. R. Behrens, N.-K. Lee, B. Liu

The paper identifies ALPPL2 as a highly specific tumor cell surface antigen for mesothelioma and demonstrates its therapeutic potential through an antibody-drug conjugate.

bioRxiv · Jan 7, 2020Cancer Biology

LegoBody: facile generation of bispecific and multi-specific antibodies

S. Lang, Y. Su, S. Bidlingmaier, N.-K. Lee, B. Liu

This study introduces a modular method to generate bispecific and multi-specific antibodies using temporary linkers and proteases, enabling efficient production with desired properties.

bioRxiv · Dec 25, 2019 · PreprintBioengineering